Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | BLISSGVS Bliss GVS Pharma Limited Pharma · Small | FDC FDC Limited Pharma · Small | ZOTA Zota Health Care LImited Pharma · Small | NOVARTIND Novartis India Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 45 | 39 | 28 | 45 |
| Verdict | WATCHLIST | WATCHLIST | OVERVALUED | WATCHLIST |
| Style | Financial Turnaround | WATCHLIST | OVERVALUED | Financial Turnaround |
| Piotroski | 8/9 | 8/9 | 5/9 | 7/9 |
| Valuation | 6/30 | 5/30 | 1/30 | 5/30 |
| Growth | 13/25 | 8/25 | 14/25 | 15/25 |
| Quality | 4/20 | 2/20 | 0/20 | 2/20 |
| Balance Sheet | 10/15 | 14/15 | 7/15 | 13/15 |
| Cash Flow | 8/10 | 5/10 | 3/10 | 5/10 |
| Price | ₹421.6 | ₹394 | ₹1,211.2 | ₹1,331.4 |
| P/E | 34.00 | 20.90 | 146.00 | 36.90 |
| P/B | 3.72 | 2.49 | 4.70 | 4.20 |
| ROE | 11.60% | 12.50% | 4.74% | 11.60% |
| ROCE | 16.80% | 16.70% | 6.68% | 16.20% |
| Debt / Equity | 0.02 | 0.01 | 0.02 | 0.00 |
| FCF Yield | 2.28% | 1.45% | — | 1.89% |
| Dividend Y | 0.12% | 1.31% | 0.08% | 1.80% |
| Altman Z | 8.38 | 8.63 | 8.00 | 8.13 |
| Promoter % | 35.36% | 69.65% | 49.38% | 70.68% |
| Mkt Cap (₹Cr) | 4439.00 | 6207.00 | 4170.00 | 3435.00 |
| Graham # | ₹176.19 | ₹243.97 | ₹215.47 | ₹530.16 |
| Fair PE | 42.0 | 8.7 | 42.0 | 42.0 |
| MoS % | +17.8% | -161.7% | -257.8% | +16.0% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startBLISSGVS339
FDC76
ZOTA205
NOVARTIND138